Format

Send to

Choose Destination
Gut. 2016 Feb;65(2):330-9. doi: 10.1136/gutjnl-2015-309990. Epub 2015 Sep 2.

The gut microbiota and host health: a new clinical frontier.

Author information

1
School of Biosciences, Museum Avenue, Cardiff University, Cardiff, UK Centre for Digestive and Gut Health, Imperial College London, London, UK.
2
NIHR Biomedical Research Unit, Centre for Liver Research, University of Birmingham, Birmingham, UK.
3
Nutrition and Nutrigenomics Group, Department of Food Quality and Nutrition, Research and Innovation Centre, Trento, Italy.
4
Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands Top Institute Food and Nutrition (TIFN), Wageningen, The Netherlands.
5
Division of Applied Medicine, School of Medicine and Dentistry, University of Aberdeen, Institute of Medical Sciences, Aberdeen, UK.
6
Section of Computational and Systems Medicine, Faculty of Medicine, Imperial College London, London, UK.
7
Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands.
8
Yakult UK Limited, Middlesex, UK.
9
IBD Unit, St Mark's Hospital and Imperial College London, London, UK.

Abstract

Over the last 10-15 years, our understanding of the composition and functions of the human gut microbiota has increased exponentially. To a large extent, this has been due to new 'omic' technologies that have facilitated large-scale analysis of the genetic and metabolic profile of this microbial community, revealing it to be comparable in influence to a new organ in the body and offering the possibility of a new route for therapeutic intervention. Moreover, it might be more accurate to think of it like an immune system: a collection of cells that work in unison with the host and that can promote health but sometimes initiate disease. This review gives an update on the current knowledge in the area of gut disorders, in particular metabolic syndrome and obesity-related disease, liver disease, IBD and colorectal cancer. The potential of manipulating the gut microbiota in these disorders is assessed, with an examination of the latest and most relevant evidence relating to antibiotics, probiotics, prebiotics, polyphenols and faecal microbiota transplantation.

KEYWORDS:

INTESTINAL BACTERIA

PMID:
26338727
PMCID:
PMC4752653
DOI:
10.1136/gutjnl-2015-309990
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center